Startups
The NCI Center for Cancer Research is dedicated to solving important, challenging and neglected problems in cancer research and patient care.
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 3, 2024 | NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy | Clinical data from a simple blood test may one day be used to match patients to immunotherapy drugs. Credit: iStock/Charday Penn What In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an arti... |
| Nov 28, 2023 | Travel Resorts of America Reviews Announces Sycamore Lodge Haunted Forest Raises More Than $30,000 for Cancer Research | Travel Resorts of America Travel Resorts of America reviews are in, and this year's three Saturday night event, the Sycamore Lodge Haunted Forest, has raised more than $30,000 for cancer research. The annual event honors the memory of Sycam... |
| Oct 24, 2023 | NIH immunotherapy pioneer Steven Rosenberg awarded nation’s highest honor for technology and innovation | Steven A. Rosenberg, M.D., Ph.D., is a recipient of the 2023 National Medal of Technology and Innovation. Credit: National Institutes of Health What Immunotherapy pioneer Steven A. Rosenberg, M.D., Ph.D., has been awarded the National Medal... |
| Jul 5, 2023 | NIH study offers insights into how cells reverse their decision to divide | Breast cancer cells going through the cell cycle. Credit: Cappell Lab What A new study suggests that cells preparing to divide can reverse this process and return to a resting state, challenging long-held beliefs about cell division. If int... |
| Apr 27, 2022 | HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials | This is a first-of-its-kind international study initiated in 2019 by HistoIndex to examine artificial intelligence (AI)-based approaches that may provide a more reliable way to assess the range of injury recorded as "hepatocyte balloon... |
| Mar 29, 2022 | Volition Signs Exclusive $28 million License and Supply Agreement with Heska Corporation to Distribute Nu.Q® Vet Cancer Screening Test at the Point of Care | AUSTIN, Texas, March 29, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced the signing of an exclusive global supply and licensing agreement with Heska ... |
| Mar 10, 2016 | Rakuten CEO leads $40M investment in photoimmunotherapy startup Aspyrian Therapeutics? | MedCity News has contacted Aspyrian Therapeutics, and is awaiting more information on how the company plans to use the funding – and who invested. The company raised about $12.7 million last year, according to regulatory filings. Photoimmun... |
| Aug 15, 2014 | Aura Biosciences nabs $4 million for its pseudovirion-based targeted cancer therapy | Aura has slowly and steadily been raising capital since its 2009 launch, with a notable 2012 raise of $3.2 million in a round that included Henri Termeer, former president of Genzyme. Gotta love this quote, though it’s dated (back to 2009!)... |
| Aura Biosciences nabs $4 million for its pseudovirion-based targeted cancer therapy | A hot segment of targeted cancer therapy is using synthetic viruses, or pseudovirions, to serve as mini drug delivery capsules. These tiny protein shells are engineered to hone in to attack certain cancerous cells – avoiding healthy tissue ... |
Show more
Reviews 0
FAQ about Center for Cancer Research
What has the press written about Center for Cancer Research?
Parsers VC has collected 11 articles mentioning Center for Cancer Research, among them “NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy” (Jun 3, 2024) and “Travel Resorts of America Reviews Announces Sycamore Lodge Haunted Forest Raises More Than $30,000 for Cancer Research” (Nov 28, 2023).
Is Center for Cancer Research still active?
Yes, Center for Cancer Research is active; its latest activity on Parsers VC dates from Aug 13, 2024.